Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v5-EN
Language English English
Date Updated 2020-06-30 2020-06-05
Drug Identification Number 01908448 01908448
Brand name BETOPTIC S BETOPTIC S
Common or Proper name BETOPTIC 0.25% SUSP. 5ML BETOPTIC 0.25% SUSP. 5ML
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients BETAXOLOL BETAXOLOL
Strength(s) 0.25% 0.25%
Dosage form(s) SUSPENSION SUSPENSION
Route of administration OPHTHALMIC OPHTHALMIC OPHTHALMIC OPHTHALMIC
Packaging size 5ML 5ML
ATC code S01ED S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2020-06-26 2020-06-26
Actual start date 2020-06-29
Estimated end date 2020-08-26 2020-08-26
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments
Health Canada comments